PBS Biotech
PBS Biotech is produces the easiest to use and most technologically-advanced bioreactors for the pharmaceutical industry.
Launch date
Employees
Market cap
-
Enterprise valuation
€80—120m (Dealroom.co estimates Jan 2023.)
Camarillo California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
$10.0m | Late VC | ||
* | $22.0m | Late VC | |
| Total Funding | €29.1m | ||
Recent News about PBS Biotech
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.